Uncategorized
Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the three months and year ended December 31, 2018. Recent Financial and Corporate Highlights: Implanted 16 Argus® II Retinal Prosthesis Systems (Argus II) worldwide in the fourth quarter